Yunxiang Zhang

7PUBLICATIONS
52CO-AUTHORS
Haematological tumoursPredictive and prognostic markersRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 14, 2026
Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.

Jingtao Huang, Huihong Huang, Yunxiang Zhang

|Feb 26, 2025
Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol.

Yunxiang Zhang, Min Wu, Zhen Jin

|Feb 28, 2024
Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia.

Peng Jin, Xiaoling Wang, Qiqi Jin

|Jul 25, 2022
Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia.

Peng Jin, Qiqi Jin, Xiaoling Wang

|Oct 23, 2021
Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: A single-arm, phase 2 trial (RJ-AML 2014).

Yunxiang Zhang, Xiaoyang Li, Xiangqin Weng

|May 13, 2020
PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma.

Min Zhao, Xiaoyang Li, Yunxiang Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Xiaoyang Li

2 joint publications

Hongming Zhu

2 joint publications

Jie Shen

2 joint publications

Peng Jin